<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="brief-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2022.1059996</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>&#x3b1;D&#x3b2;2 as a novel target of experimental polymicrobial sepsis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Koutsogiannaki</surname>
<given-names>Sophia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1656029"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hou</surname>
<given-names>Lifei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1566622"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Okuno</surname>
<given-names>Toshiaki</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shibamura-Fujiogi</surname>
<given-names>Miho</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Hongbo  R.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/813304"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yuki</surname>
<given-names>Koichi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/991522"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Anesthesiology, Critical Care and Pain Medicine, Cardiac Anesthesia Division, Boston Children&#x2019;s Hospital</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Anaesthesia, Harvard Medical School</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Immunology, Harvard Medical School</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Biochemistry, Juntendo University Faculty of Medicine</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Pathology, Boston Children&#x2019;s Hospital</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Zuliang Jie, Xiamen University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Mehmet Sen, University of Houston, United States; Yuejin Liang, University of Texas Medical Branch at Galveston, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Koichi Yuki, <email xlink:href="mailto:koichi.yuki@childrens.harvard.edu">koichi.yuki@childrens.harvard.edu</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>11</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>1059996</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>10</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Koutsogiannaki, Hou, Okuno, Shibamura-Fujiogi, Luo and Yuki</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Koutsogiannaki, Hou, Okuno, Shibamura-Fujiogi, Luo and Yuki</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Since sepsis was defined three decades ago, it has been a target of intensive study. However, there is no specific sepsis treatment available, with its high mortality and morbidity. &#x3b1;D&#x3b2;2 (CD11d/CD18) is one of the four &#x3b2;2 integrin members. Its role in sepsis has been limitedly studied. Using an experimental polymicrobial sepsis model, we found that the deficiency of &#x3b1;D&#x3b2;2 was associated with less lung injury and better outcome, which was in sharp contrast to other &#x3b2;2 integrin member &#x3b1;L&#x3b2;2 (CD11a/CD18), and &#x3b1;M&#x3b2;2 (CD11b/CD18). This phenotype was supported by a reduction of bacterial loads in &#x3b1;D&#x3b2;2 knockout mice. Further analysis showed that the deficiency of &#x3b1;D&#x3b2;2 led to a reduction of neutrophil cell death as well as an increase in neutrophil phagocytosis in both murine and human systems. Our data showed a unique role of &#x3b1;D&#x3b2;2 among the &#x3b2;2 integrin members, which would serve as a potential target to improve the outcome of sepsis.</p>
</abstract>
<kwd-group>
<kwd>integrin</kwd>
<kwd>aDb2</kwd>
<kwd>sepsis</kwd>
<kwd>cell death</kwd>
<kwd>phagocytosis</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Institute of Child Health and Human Development<named-content content-type="fundref-id">10.13039/100000071</named-content>
</contract-sponsor>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="39"/>
<page-count count="12"/>
<word-count count="5396"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Sepsis remains to be a huge health care burden. Sepsis is the leading cause of death in the non-cardiac intensive care units (ICUs), accounting for more than 750,000 deaths annually in the U.S. Lack of specific treatment against sepsis is largely responsible for its high morbidity and mortality. Sepsis is treated conservatively with antibiotic administration, fluid resuscitation, and respiratory support. Thus, the development of a therapeutic to attenuate sepsis is urgently needed.</p>
<p>&#x3b2;2 integrins are a leukocyte-specific glycoprotein adhesion molecule family consisting of &#x3b1;- and &#x3b2;-subunits responsible for a number of leukocyte functions during infection. The critical role of &#x3b2;2 integrins in infection is well illustrated by a rare genetic disease called leukocyte adhesion deficiency type I (LAD I), which is caused by a functional or expressional defect of &#x3b2;2 integrins, and characterized by recurrent infection, sepsis, and death (<xref ref-type="bibr" rid="B1">1</xref>). &#x3b2;2 integrins consist of the four members; &#x3b1;L&#x3b2;2 (CD11a/CD18, leukocyte function-associated antigen-1), &#x3b1;M&#x3b2;2 (CD11b/CD18, macrophage 1-antigen), &#x3b1;X&#x3b2;2 (CD11c/CD18), and &#x3b1;D&#x3b2;2 (CD11d/CD18). Among them, &#x3b1;L&#x3b2;2 and &#x3b1;M&#x3b2;2 have been extensively studied. &#x3b1;L&#x3b2;2 is ubiquitously expressed on leukocytes, and involved in a number of important leukocyte functions including trafficking and immunological synapse formation (<xref ref-type="bibr" rid="B2">2</xref>). &#x3b1;M&#x3b2;2 is expressed mainly on innate immune cells, and plays a major role in their recruitment and phagocytosis (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Both &#x3b1;L&#x3b2;2 and &#x3b1;M&#x3b2;2 deficiency significantly worsened infection and sepsis outcome (<xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B7">7</xref>). &#x3b1;X&#x3b2;2 (CD11c) is widely known as a dendritic cell marker, and its deficiency also worsened the sepsis outcome (<xref ref-type="bibr" rid="B8">8</xref>). &#x3b1;D&#x3b2;2 was cloned last among the &#x3b2;2 integrins, and the investigation on the role of &#x3b1;D&#x3b2;2 in sepsis has been limited.</p>
<p>The inhibition of &#x3b2;2 integrins as a whole may not be desirable based on LAD I phenotype. However, the blockade of &#x3b2;2 integrins mitigated lung injury in sepsis (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>), suggesting that a subset of the &#x3b2;2 integrins serves as a potential target for sepsis treatment. Here we hypothesized that the inhibition of a subset of &#x3b2;2 integrin members would serve to protect from lung injury and lead to the improvement of sepsis outcome. Accordingly, the aim of this study was to determine the role of each &#x3b2;2 integrin member in the development of sepsis-associated lung injury. We found that &#x3b1;D&#x3b2;2 played a unique role in sepsis among the &#x3b2;2 integrin members so that its inhibition led to the improvement of sepsis outcome with less lung injury.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Mice</title>
<p>Wild type (<xref ref-type="bibr" rid="B11">11</xref>), CD11a (&#x3b1;L) knockout (KO) mice (<xref ref-type="bibr" rid="B12">12</xref>), CD11b (&#x3b1;M) KO mice (<xref ref-type="bibr" rid="B13">13</xref>), CD11d (&#x3b1;D) KO mice (<xref ref-type="bibr" rid="B14">14</xref>) were obtained from Jackson Laboratory (Bar Harbor, Maine, USA). CD11c (&#x3b1;X) KO mice were kindly given by Dr. Christie Ballantyne (Baylor University). CD18 KO (&#x3b2;2) KO mice were kindly given by Dr. Dennis Wagner (Boston Children&#x2019;s Hospital). They were housed under specific pathogen-free condition, with 12-hour light and dark cycles. All animal protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at Boston Children&#x2019;s Hospital.</p>
</sec>
<sec id="s2_2">
<title>CLP surgery</title>
<p>All the experimental procedures complied with institutional and federal guidelines regarding the use of animals in research. Polymicrobial abdominal sepsis was induced by cecal ligation and puncture surgery, as we previously performed (<xref ref-type="bibr" rid="B7">7</xref>). In brief, mice were anesthetized with an intraperitoneal injection of ketamine 60 mg/kg and xylazine 5 mg/kg. Following its exteriorization, the cecum was ligated at a 1.0&#xa0;cm from its tip and subjected to a single, through- and -through puncture using a 20-gauge needle. A small amount of fecal material was expelled with a gentle pressure to maintain the patency of puncture sites. The cecum was reinserted into the abdominal cavity. 0.1 mL/g of warmed saline was administered subcutaneously. Buprenorphine was given subcutaneously to alleviate postoperative surgical pain. For outcome study, mice were observed up to 7 days.</p>
</sec>
<sec id="s2_3">
<title>Lung injury analysis</title>
<p>For histological analysis, lung was fixed with 4% paraformaldehyde for histological analysis. Lung histology was subjected to Hematoxylin and Eosin (H&amp;E) staining. In some cases, we also examined bronchial lavage fluid (BAL) for protein concentrations, and performed wet to dry ratio.</p>
</sec>
<sec id="s2_4">
<title>Quantitative organ culture</title>
<p>To determine the bacterial loads in the organs and blood, tissue homogenates or blood were loaded on 5% blood agar plates (Teknova; Hollister, California, USA) after surgical dilutions and incubated for 18 hours as previously described (<xref ref-type="bibr" rid="B15">15</xref>). Colonies of all morphologies on plates were counted. For neutrophil depletion experiment, 250 &#xb5;g of rat anti-Ly6G antibody (clone 1A8, Bio X Cell, Lebanon, NH) was injected intraperitoneally one day before CLP procedure as previously described (<xref ref-type="bibr" rid="B16">16</xref>). As a control, normal rat IgG2a isotype control was used.</p>
</sec>
<sec id="s2_5">
<title>
<italic>Escherichia coli</italic> intraabdominal infection model</title>
<p>Escherichia coli (<italic>E. coli</italic>)-GFP (ATCC25922-GFP) was overnight cultured in Luria-Bertani (<xref ref-type="bibr" rid="B17">17</xref>) ampicillin (100 &#xb5;g/mL) medium at 37&#xb0;C and washed twice with sterile PBS buffer. Mice were subjected to an intraperitoneal injection of <italic>E. coli</italic>- GFP (10<sup>8</sup> CFU). At 6 hours after the injection, peritoneal fluid was collected by lavage using 5 mL of cold PBS buffer. Serial dilutions of the final bacterial inocula were plated on LB-ampicillin (100 &#xb5;g/mL) agar plates and incubated overnight at 37&#xb0;C to verify the number of live bacteria injected as above.</p>
</sec>
<sec id="s2_6">
<title>Cell death assay</title>
<p>Cell death was examined using Annexin V apoptosis detection kit (BD Biosciences, San Jose, CA, USA). Briefly cells were stained with Annexin V-FITC. Then, cells were subjected to flow cytometry analysis using BD Accuri C6 (BD Biosciences).</p>
</sec>
<sec id="s2_7">
<title>Chimeric mouse experiments</title>
<p>To generate mixed bone marrow chimeras, recipient mice on the C57BL/6 background were irradiated with two doses of 550&#xa0;rad with 4-hour intervals. Wild-type (WT; CD45.1) and CD11dKO&#xa0;(CD45.2) derived bone marrow cells (total of 5 &#xd7; 10<sup>6</sup>&#xa0;cells) were mixed at the ratio of 1:1 and injected into the tail vein of lethally irradiated recipients. Mice were evaluated for the reconstitution of the immune compartment at various time points after bone marrow transplantation. To prevent bacterial infection, the mice were provided with autoclaved drinking water containing sulfatrim for 1 week prior to and for 4 weeks after irradiation.</p>
</sec>
<sec id="s2_8">
<title>Phagocytosis</title>
<p>The neutrophil phagocytosis was done using Phagotest Kit (Glycotope Biotechnology; Heidelberg, Germany). Mouse neutrophils were incubated in complete RPMI 1640 on ice for 10&#xa0;min, followed by the addition of FITC-<italic>E. Coli</italic>. Then the neutrophil suspension was kept on ice as cold control or was put into 37&#xb0;C water bath for 10&#xa0;min. At the end of incubation, cells were transferred back on ice, quenched, and washed. Cells were suspended in PBS/1% PFA and measured by BD Accuri C6 (BD Biosciences).</p>
</sec>
<sec id="s2_9">
<title>Reactive oxygen species</title>
<p>Mouse neutrophils (2 &#xd7; 10<sup>5</sup> in 200 &#xb5;l) were cultured in complete RPMI 1640 at 37&#xb0;C for 30&#xa0;min. Dihydrorhodamine-123 (1 &#xb5;M; Sigma-Aldrich) was added for 5&#xa0;min at 37&#xb0;C. Neutrophils were washed once. PMA (100 nM) was added, and the cells were incubated for additional 15&#xa0;min at 37&#xb0;C. After one wash, the cells were resuspended in cold PBS with 1% FCS for detection of ROS-induced rhodamine-123 on BD Accuri C6 (BD Biosciences).</p>
</sec>
<sec id="s2_10">
<title>Chemotaxis</title>
<p>Bone marrow neutrophils were subjected to horizontal chemotaxis assay using the EZ-TAXIScan apparatus (Effector Cell Institute; Tokyo, Japan) as previously performed. Neutrophils suspended in RPMI1640 containing 10 mM HEPES, 0.1% BSA and 10 mM EDTA were aligned on one edge of the chemotaxis channel. At the other end, 1 &#xb5;M N-formylmethionine-leucyl-phenylalanine (fMLP) was injected, creating a gradient along the channel. Pictures were taken every 30 seconds for 20min, and recorded movies were analyzed using FIJI software (National Institute of Health; Bethesda, MD).</p>
</sec>
<sec id="s2_11">
<title>Eicosanoid lipidomics</title>
<p>Reverse-phase mass spectrometry (MS)-based quantitation technique for eicosanoids was previously described (<xref ref-type="bibr" rid="B18">18</xref>). The lipids were extracted with methanol and diluted with water containing 0.1% formic acid to yield a final methanol concentration of 20%. After addition of deuterium-labeled internal standards, the samples were loaded on Oasis HLB cartridge (Waters, Milford, MA). The column was washed with 1 mL of water, 1 mL of 15% methanol, and 1 mL of petroleum ether and then eluted with 0.2 mL of methanol containing 0.1% formic acid. Eicosanoids were quantified by reverse-phase-HPLC-electrospray ionization-tandem MS method.</p>
</sec>
<sec id="s2_12">
<title>RNA sequencing</title>
<p>Blood or lung cells were stained with anti-Ly6G, CD11b, and CD45.2 antibodies. Neutrophils were sorted as Ly6G<sup>+</sup>/CD11b<sup>+</sup>/CD45.2<sup>+</sup> population. They were subjected to RNA purification using Qiagen RNeasy Plus Mini Kit. RNA samples were quantified using Qubit 2 Fluorometer (Life Technology; Carlsbad, CA) and RNA integrity was checked with Agilent TapeStation (Agilent Technologies; Palo Alto, CA). SMART-Seq v4 Ultra Low Input kit for Sequencing was used for full-length cDNA synthesis and amplification (Clonetech; Mountain View, CA), and Illumina Nextera XT library was used for sequencing library preparation. Briefly, cDNA was fragmented, and adaptor was added using transposase, followed by limited-cycle PCR to enrich and add index to the cDNA fragments. The final library was assessed with Qubit 2.0 Fluorometer and Agilent TapeStation. The sequencing libraries were multiplexed and clustered on one lane of a flowcell. After clustering, the flowcell was loaded on the Illumina HiSeq instrument according to the manufacturer&#x2019;s instructions. The samples were sequenced using a 2x150 paired end configuration. After investigating the quality of the raw data, sequencing reads were trimmed to remove possible adapter sequences and nucleotides with poor quality using Trimmomatic v.0.36. The trimmed reads were mapped to the mouse reference genome using STAR aligner v.2.5.2b. Only unique reads that fell within exon regions were counted. After extraction of gene hit counts, the gene hit counts table was used. Using DESeq2, a comparison between the groups of samples was performed. The Wald test was used to generate p-value and Log<sub>2</sub> fold changes. Genes with adjusted p-values &lt; 0.05 and absolute log<sub>2</sub> fold change &gt; 1 were called differentially expressed genes. Data are available at GSE215749 (GEO).</p>
</sec>
<sec id="s2_13">
<title>CRISPR/Cas9 deletion of Itgad gene in HL-60 cells</title>
<p>CRISPR/Cas9 editing to delete &#x3b1;D (gene: Itgad) expression was done in HL-60 cells as follows. HL-60 cells were cultured at 37&#xb0;C in RPMI1640 supplemented with 10% FBS, 1% penicillin/streptomycin. Confluency was maintained between 3 x10<sup>5</sup>-1.5x 10<sup>6</sup>/ml. Electroporation was performed one day after passaging when cells were in log phase of growth using the Lonza 4D Nucleofector with 20 &#xb5;l Nucleocuvette strips as described (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). Briefly, ribonucleoprotein (RNP) complex was made by combining 100 pmol Cas9 (IDT; Newark, NJ) and 100pmol modified sgRNA (Synthego; Redwood City, CA) targeting ITGAD using either sg1 (UUCUUAUCAUGGAUUCAACC) or sg2 (AUGAUAAGAAGCCAGGACUG) and incubating at room temperature for 15 minutes.</p>
<p>2 x10<sup>5</sup>- 4 x 10<sup>5</sup> HL-60 cells were resuspended in 20 &#xb5;l SF cell line solution (Lonza; Basel, Switzerland) and were mixed with RNP and underwent nucleofection with program EN-138 as per manufacturer recommendations. Cells were returned to RPMI1640 media and editing efficiency was measured 48 hours after electroporation by polymerase chain reaction (PCR). First, genomic DNA was extracted using the DNeasy kit (Qiagen; Hildgen, Germany) according to the manufacturer&#x2019;s instructions. Genomic PCR was performed using Platinum II Hotstart Mastermix (Thermo Fischer Scientific), and edited allele frequency was detected by Sanger sequencing and analyzed by ICE (<xref ref-type="bibr" rid="B21">21</xref>). The following primer pairs were used: ITGAD (forward: ATGATAAGAAGCCAGGACTG; reverse: CAGTCCTGGCTTCTTATCAT).</p>
</sec>
<sec id="s2_14">
<title>Statistical analysis</title>
<p>Data were analyzed as indicated in the figure legends. Statistical analysis methods were included under each figure legend. Statistical significance was defined as P&lt;0.05. All the statistical calculations were performed using PRISM9 software (GraphPad Software, La Jolla, CA).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>&#x3b1;D&#x3b2;2 deficiency attenuated lung injury and improved survival in experimental polymicrobial abdominal sepsis</title>
<p>Polymicrobial abdominal sepsis induced by CLP surgery is the most frequently used preclinical sepsis model that best recapitulates human sepsis (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). We previously reported that sepsis outcomes of &#x3b1;L KO, &#x3b1;M KO and &#x3b1;X KO mice were worse than that of wild-type (<xref ref-type="bibr" rid="B11">11</xref>) mice in this model (<xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B7">7</xref>). Because blocking &#x3b2;2 integrin as a whole attenuated lung injury (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>), we examined the degree of lung injury in mice deficient of each of the &#x3b2;2 integrin members. In line, &#x3b2;2 KO mice had less lung injury following CLP (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). Histological analysis demonstrated that lung injury was highly induced following sepsis in WT, &#x3b1;L KO, and &#x3b1;M KO mice (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). In contrast, &#x3b1;D KO mice manifested less histological lung injury (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). Wet-to-dry and BAL fluid analyses also supported the finding (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). &#x3b1;D KO mice also showed better survival compared to WT mice (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>), suggesting that &#x3b1;D&#x3b2;2 may be a good target to attenuate sepsis. We further examined bacterial loads at various organs. Bacterial loads at the lungs, spleen, kidney, and blood were significantly less in &#x3b1;D KO mice (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>), consistent with the survival data. However, bacterial loads at the peritoneal cavity did not show any difference between the two strains (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). Neutrophils are the first-line defense immune cells critical for bacterial eradication (<xref ref-type="bibr" rid="B24">24</xref>). The relationship between neutrophil numbers in the blood, the peritoneal cavity, and the lungs between the two strains correlated with the data of bacterial loads above (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>), suggesting that the difference in neutrophil numbers at various sites was in part responsible for the degree of bacterial clearance. CLP sepsis is a sepsis with mixed bacterial flora. Considering the possibility that the flora between the two strains would not likely be the same., we also examined bacterial clearance in <italic>E. coli</italic> intraperitoneal injection model. Bacterial loads were significantly less in &#x3b1;D KO mice at 6 hours after an intraperitoneal injection (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>), indicating that integrin &#x3b1;D deficiency might enhance bacterial eradication.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The role of &#x3b1;D&#x3b2;2 in sepsis. <bold>(A)</bold> Representative lung histology of WT, &#x3b1;L KO, &#x3b1; KO, and &#x3b2;2 KO mice at the baseline and at 12 hours after CLP. Black bar indicates 50 &#xb5;m. <bold>(B)</bold> Representative lung histology of WT and &#x3b1;D KO at the baseline, at 12 and 36 hours after CLP. Wet to lung analysis and BAL total protein analysis at the baseline and at 12 hours after CLP. Data were shown as mean +/- S.D. of 6 mice per group. One-way ANOVA with Bonferroni <italic>post hoc</italic> analysis was performed. **p &lt; 0.01, ***p &lt; 0.001. <bold>(C)</bold> Survival after CLP in WT (n=18), &#x3b1;D KO (n=12) and &#x3b2;2 KO (n=15) mice. Cox regression analysis was performed. *p &lt;0.05, **p &lt;0.01. <bold>(D)</bold> Bacterial loads in WT and &#x3b1;D KO mice at 12 hours after CLP. Data were shown as mean +/- S.D. of 8 mice per group. Two-way ANOVA analysis was performed. *p &lt; 0.05. <bold>(E)</bold> Neutrophil counts at the lungs, the blood, and the peritoneal cavity in WT and &#x3b1;D KO mice at 12 hours after CLP. Data were shown as mean +/- S.D. of 6 mice. Student t test was performed. *P &lt; 0.05, p &lt; 0.01. <bold>(F)</bold> Bacterial loads at the peritoneal cavity at 6 hours after <italic>E coli</italic> intraperitoneal injection. Data were shown as mean +/- S.D. of 6 mice. Student t test was performed. *p &lt; 0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1059996-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>&#x3b1;D&#x3b2;2 KO neutrophils helped to eradicate bacterial loads in the lungs preferentially</title>
<p>The correlation of the degree of splenic apoptosis with sepsis outcome has been previously described (<xref ref-type="bibr" rid="B25">25</xref>&#x2013;<xref ref-type="bibr" rid="B27">27</xref>). Splenic neutrophil and monocyte cell death was significantly less in &#x3b1;D KO mice (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>), consistent with the sepsis outcome data above. However, the degree of cell death was comparable in T and B cells between WT and &#x3b1;D KO mice (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). The expression of &#x3b1;D&#x3b2;2 was previously reported on neutrophils and monocytes/macrophages (<xref ref-type="bibr" rid="B28">28</xref>). We examined the contribution of neutrophils to CLP sepsis in both WT and &#x3b1;D KO mice by depleting neutrophils using 1A8 antibody. Neutrophil depletion worsened both lung and peritoneal bacterial loads in WT mice, but it significantly worsened only lung bacterial loads in &#x3b1;D KO mice (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>), which would likely be due to the difference in lung bacterial loads after CLP between the two strains. While lung bacterial loads were significantly lower in &#x3b1;D KO mice receiving isotype control compared to WT mice receiving isotype control, they were comparable between WT and &#x3b1;D KO mice subjected to neutrophil depletion.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>The functional of &#x3b1;D&#x3b2;2 in neutrophils. <bold>(A)</bold> WT and &#x3b1;D KO lung leukocyte Annexin V expression at the baseline and at 12 hours after CLP. Data were shown as mean +/- S.D. of 4 mice. MFI; mean fluorescence intensity. One-way ANOVA with Bonferroni <italic>post hoc</italic> analysis was performed. *p &lt; 0.05. <bold>(B)</bold> Bacterial loads at the lungs and the peritoneal lavage in WT and &#x3b1;D KO mice with or without neutrophil depletion. Mice were subjected to CLP sepsis and the samples were obtained at 12 hours after CLP. Data were shown as mean +/- S.D. of 6 mice. One-way ANOVA with Bonferroni <italic>post hoc</italic> analysis was performed. *p &lt; 0.05, **p &lt; 0.01. <bold>(C)</bold> Chimera scheme. <bold>(D)</bold> Blood and lung neutrophil analysis of chimeric mice at 12 hours after CLP. Data were shown as mean +/- S.D. of 4 mice. One-way ANOVA with Bonferroni <italic>post hoc</italic> analysis was performed. *p &lt; 0.05. <bold>(E)</bold> Lung and peritoneal cavity LTB<sub>4</sub> levels at 6 and 12 hours after CLP. Data were shown as mean +/- S.D. of 4 mice. One-way ANOVA with Bonferroni <italic>post hoc</italic> analysis was performed. *p &lt; 0.05. <bold>(F)</bold> LTB<sub>4</sub> mediated bone marrow neutrophil chemotaxis assay. Each dot represents one neutrophil. One-way ANOVA with Bonferroni <italic>post hoc</italic> analysis was performed. No significance was observed. <bold>(G)</bold> Lung neutrophil ROS activity from na&#xef;ve and post CLP mice. For CLP mice, lungs were obtained at 12 hours after CLP. Data were shown as mean +/- S.D. of 6 mice. One-way ANOVA with Bonferroni <italic>post hoc</italic> analysis was performed. No significance was observed. <bold>(H)</bold> Lung neutrophil phagocytosis activity from na&#xef;ve and post CLP mice. For CLP mice, lungs were obtained at 12 hours after CLP. Data were shown as mean +/- S.D. of 6 mice. One-way ANOVA with Bonferroni <italic>post hoc</italic> analysis was performed. **p &lt; 0.01. <bold>(I)</bold> Lung neutrophil Annexin V expression from na&#xef;ve and post CLP mice. For CLP mice, lungs were obtained at 12 hours after CLP. Data were shown as mean +/- S.D. of 6 mice. One-way ANOVA with Bonferroni <italic>post hoc</italic> analysis was performed. **p &lt; 0.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1059996-g002.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>&#x3b1;D KO neutrophil demonstrated higher phagocytic ability, less apoptosis and more tissue recruitment</title>
<p>Although we observed the difference in neutrophil numbers in the lungs between WT and &#x3b1;D KO mice, it is yet to be determined if the result was intrinsically derived from integrin &#x3b1;D. To validate if the result of higher &#x3b1;D KO neutrophil numbers in the lungs is intrinsic, we generated mixed bone marrow chimera to harbor both WT and &#x3b1;D KO mice-derived hematopoietic systems, which were distinguished by congenic markers CD45.1 and CD45.2, respectively. Control mixed chimeras were made by the reconstitution of CD45.1 and CD45.2 WT bone marrow cells (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). At 12 weeks after bone marrow transplantation, we examined peripheral blood and confirmed the peripheral blood leukocytes were constituted equally by CD45.1 and CD45.2 cells (data not shown). We found that more &#x3b1;D KO derived neutrophils existed in the lungs compared to WT (CD45.1) neutrophils, supporting that the phenotype was intrinsic to &#x3b1;D KO neutrophils (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>). LTB<sub>4</sub> is a major neutrophil chemoattractant. At 6 and 12 hours after CLP in WT and &#x3b1;D KO mice, we observed LTB<sub>4</sub> level was significantly higher in the lungs of &#x3b1;D KO mice (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>). In contrast, peritoneal LTB<sub>4</sub> level was not statistically significant between the strains. We did not see any difference in neutrophil recruitment to neutrophil chemoattractant LTB<sub>4</sub> <italic>in vitro</italic> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2F</bold>
</xref>), indicating that the difference of numbers between WT and &#x3b1;D KO neutrophils in chimera&#x2019; lungs was not driven by chemotaxis. Here we examined the role of &#x3b1;D&#x3b2;2 in neutrophils using WT and &#x3b1;D KO neutrophils. The level of reactive oxygen species (ROS) production was comparable between WT and &#x3b1;D KO mice (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2G</bold>
</xref>), while there was an increased phagocytosis by lung &#x3b1;D KO neutrophils (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2H</bold>
</xref>), supporting the result of the <italic>E. coli</italic> injection model (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1F</bold>
</xref>). To examine if higher &#x3b1;D KO neutrophil counts in the lung is explained by neutrophil survival, we also examined the cell death of lung neutrophils. Consistent with the result of splenic neutrophil apoptosis, the cell death of &#x3b1;D KO lung neutrophils was less compared to WT neutrophils (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2I</bold>
</xref>), which at least in part explains these results. Taken together, &#x3b1;D KO mice demonstrated a difference in neutrophil phenotypes characterized as less cell death and more efficient phagocytosis in the lungs. Higher lung &#x3b1;D KO neutrophil counts will be likely in part responsible for less neutrophil cell death.</p>
</sec>
<sec id="s3_4">
<title>&#x3b1;D KO neutrophil transcriptomic analysis demonstrated the association between &#x3b1;D and proliferation, and phagocytosis</title>
<p>To further characterize &#x3b1;D KO neutrophils, we performed transcriptomic analysis of blood and lung neutrophils. We found only 5 DEGs in blood and 7 DEGs in lung between WT and &#x3b1;D KO mice at the baseline. One DEG was overlapped between blood and lung. This result suggested that the transcriptomic signature of WT and &#x3b1;D KO neutrophils in the blood and lung at the baseline was quite similar (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). The DEG analysis of &#x3b1;D KO neutrophils at 12 hours post CLP vs at the baseline (time 0h) in blood and lung showed that there was no DEG in lung, suggesting that there was no DEGs in the lung between baseline and 12 hours post-CLP (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). When we compared lung neutrophils between WT and &#x3b1;D KO mice, we identified 55 upregulated DEGs and 90 upregulated DEGs in &#x3b1;D KO lung neutrophils (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). Upregulated genes include phagocytosis related genes (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>), and downregulated genes include cell arrest and proliferation genes (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>RNA sequencing of blood and lung neutrophils following CLP sepsis. RNA seq of triplicates for blood and lung neutrophils at baseline and 12 hours after CLP. Neutrophils were sorted by CD45<sup>+</sup>Ly6G<sup>+</sup>CD11b<sup>+</sup> population. <bold>(A)</bold> Venn diagram showing significant DEGs in the blood and lung of &#x3b1;D KO mice at 0h post-CLP compared to WT mice at 0h post-CLP. The light pink circle represents DEGs in the blood of &#x3b1;D KO mice at 0h post-CLP compared to the blood of WT mice at 0h post-CLP. The deep pink circle represents DEGs in the lung of &#x3b1;D KO mice at 0h post-CLP compared to the lung of WT mice at 0h post-CLP. The intersection of the two circles represents overlapping DEGs in the blood and lung of &#x3b1;D KO mice at 0h post-CLP compared to WT mice at 0h post-CLP. Overall, only 5 genes were differentially expressed in the blood of &#x3b1;D KO and 7 genes in the lungs of &#x3b1;D KO compared to the WT mice at the baseline (0h post-CLP) and 4 of these DEGs were common in the blood and lung, suggesting no significant differences in the transcriptomic profile of WT and &#x3b1;D KO mice at the baseline. <bold>(B)</bold> Venn diagram showing significant DEGs in the blood and lung of &#x3b1;D KO mice at 12h post-CLP compared to &#x3b1;D KO mice at 0h post-CLP. The light blue circle represents DEGs in the blood of &#x3b1;D KO mice at 12h post-CLP compared to the blood of &#x3b1;D KO mice at 0h post-CLP. The green circle represents DEGs in the lung of &#x3b1;D KO mice at 12h post-CLP compared to the lung of &#x3b1;D KO mice at 0h post-CLP. The intersection of the two circles represents overlapping DEGs in the blood and lung of &#x3b1;D KO mice at 12h post-CLP compared to &#x3b1;D KO mice at 0h post-CLP. Overall, 2448 genes were differentially expressed in the blood of &#x3b1;D KO at 12h post-CLP compared to 0h post-CLP and none was observed in the lungs, suggesting no differences in the transcriptomic profile of the lungs of &#x3b1;D KO mice between 0h and 12h post-CLP. <bold>(C)</bold> Venn diagram showing significant DEGs in the lung of &#x3b1;D KO mice at 12h post-CLP compared to WT mice at 12h post-CLP. The green circle represents DEGs upregulated in the lung of &#x3b1;D KO mice at 12h post-CLP compared to the lung of WT mice at 12h post-CLP. The blue circle represents DEGs downregulated in the lung of &#x3b1;D KO mice at 12h post-CLP compared to the lung of WT mice at 12h post-CLP. The intersection of the two circles represents overlapping DEGs in lung of &#x3b1;D KO mice at 12h post-CLP compared to WT mice at 12h post-CLP. Overall, 55 genes were significantly upregulated and 90 were significantly downregulated in the lung of &#x3b1;D KO at 12h post-CLP compared to WT mice at 12h post-CLP and these DEGs were used for pathway enrichment analysis <bold>(D, E)</bold>. <bold>(D)</bold> Pathway Enrichment Analysis (GO) of upregulated DEGs in the lung of &#x3b1;D KO mice at 12h post-CLP compared to WT mice at 12h post-CLP. Genes with adjusted p-values &lt; 0.05 and absolute log2 fold change &gt; 1 were considered differentially expressed genes. Heat map was created by plotting the enriched pathways and the genes that have contributed to the enrichment signal (indicated in deep blue). <bold>(E)</bold> Analysis of downregulated DEG pathway in lung of &#x3b1;D KO mice at 12h post-CLP compared to WT mice at 12h post-CLP. Genes with adjusted p-values &lt; 0.05 and absolute log2 fold change &gt; 1 were called differentially expressed genes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1059996-g003.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Human validation</title>
<p>Human neutrophils were previously reported to express &#x3b1;D&#x3b2;2 (<xref ref-type="bibr" rid="B29">29</xref>). To determine the role of &#x3b1;D&#x3b2;2 in human neutrophils, we performed CRISPR/Cas9 deletion of &#x3b1;D in HL-60 cells. Expression of &#x3b1;D was confirmed by flow cytometry (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>The role of &#x3b1;D&#x3b2;2 in human HL60 cells. <bold>(A)</bold> &#x3b1;D expression of HL60 cells with or without &#x3b1;D CRISPR/Cas9 deletion. Representative data was shown. <bold>(B)</bold> Phagocytosis, <bold>(C)</bold> ROS, and <bold>(D)</bold> Annexin V expression of HL60 cells with or without &#x3b1;D CRISPR/Cas9 deletion. Data were shown as mean +/- S.D. of triplicates. Sg1 and sg2 denote two different guide RNA. One-way ANOVA with Bonferroni <italic>post hoc</italic> analysis was performed. *P &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1059996-g004.tif"/>
</fig>
<p>Phagocytosis, ROS, and apoptosis were examined. We found that phagocytosis was significantly enhanced in &#x3b1;D KO HL-60 cells compared to the control (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). No difference in ROS was observed (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). Cell death was attenuated in &#x3b1;D KO HL-60 cells (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>). This is consistent with the findings in murine experiment, indicating the relevance of our findings in human.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Integrin &#x3b1;D&#x3b2;2 was the last &#x3b2;2 integrin member cloned (<xref ref-type="bibr" rid="B30">30</xref>). &#x3b2;2 integrins work by binding to their ligands. Ligands for &#x3b1;L&#x3b2;2 include intercellular adhesion molecule (ICAM)-1, -2, and -3, while &#x3b1;M&#x3b2;2 and &#x3b1;X&#x3b2;2 bind to iC3b, ICAM-1, and fibrinogen. So far &#x3b1;D&#x3b2;2 reportedly binds to ICAM-3, VCAM-1, and 2-(&#x3c9;-carboxyethyl)pyrrole (CEP) (<xref ref-type="bibr" rid="B31">31</xref>). Those ligands have been reported from <italic>in vitro</italic> experiments, but how these ligand-&#x3b1;D&#x3b2;2 interactions play a role <italic>in vivo</italic> has not been largely studied. &#x3b1;D&#x3b2;2 expression on macrophages (<xref ref-type="bibr" rid="B30">30</xref>) and neutrophils (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B32">32</xref>) has been reported. Foam cells are a type of macrophages that localize to fatty deposits on blood vessels. &#x3b1;D&#x3b2;2 deficiency was associated with less lipid deposition in the atherosclerosis model (<xref ref-type="bibr" rid="B28">28</xref>). The involvement of &#x3b1;D&#x3b2;2 in spinal cord injury was also described in the context of neutrophil invasion. The administration of anti-&#x3b1;D antibody attenuated spinal cord injury in rats (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). In the context of infection, de Azevedo-Quintanilha et&#xa0;al. reported that &#x3b1;D KO mice demonstrated less lung injury in Malaria infection model (<xref ref-type="bibr" rid="B34">34</xref>). Here we reported a novel role of &#x3b1;D&#x3b2;2 in sepsis model. The deficiency of &#x3b1;D&#x3b2;2 attenuated lung injury and sepsis outcome, which is significantly important given that a specific treatment is urgently needed for sepsis.</p>
<p>For the first time, we showed that the deficiency of &#x3b1;D&#x3b2;2 led to 1) the enhancement of phagocytosis and 2) the attenuation of cell death in neutrophils. This finding is interesting in contrast to &#x3b1;M&#x3b2;2. &#x3b1;M&#x3b2;2 is also called complement receptor 3 (CR3), and serves as one of the major phagocytosis receptors by binding to iC3b. &#x3b1;M&#x3b2;2 also affects apoptosis. The deficiency of &#x3b1;M&#x3b2;2 leads to the defect in apoptosis in the setting of infection (<xref ref-type="bibr" rid="B13">13</xref>). The mechanism of apoptosis induction <italic>via</italic> &#x3b1;M&#x3b2;2 is not completely delineated yet, but it is proposed that phagocytosis of iC3b coated microbes induces ROS production, which leads to apoptosis (<xref ref-type="bibr" rid="B35">35</xref>). The major phagocytosis receptors include Fc&#x3b3; receptor and &#x3b1;M&#x3b2;2. At this point, it is unclear how the deficiency of &#x3b1;D&#x3b2;2 leads to an enhancement of phagocytosis. Given that &#x3b1;M&#x3b2;2 and &#x3b1;D&#x3b2;2 have high sequence homology, &#x3b1;D&#x3b2;2 could compete iC3b coated microbes against &#x3b1;M&#x3b2;2. However, iC3b has not been reported as a ligand for &#x3b1;D&#x3b2;2. In addition, the attenuation of apoptosis by &#x3b1;D&#x3b2;2 is also confusing. If &#x3b1;D&#x3b2;2 deficiency increases phagocytosis, ROS may increase, leading to more apoptosis based on the theory of &#x3b1;M&#x3b2;2-mediated apoptosis.</p>
<p>The HL-60 cell experiment showed that the effect of &#x3b1;D&#x3b2;2 on cell death is cell intrinsic. Thus, it is interesting how &#x3b1;D&#x3b2;2 plays a functional role within neutrophils. Although &#x3b1;L&#x3b2;2 and &#x3b1;M&#x3b2;2 bind to ligands outside their cells for their activity, we previously reported that &#x3b1;X&#x3b2;2 has its own ligand within neutrophils. It may be possible that &#x3b1;D&#x3b2;2 has its intrinsic ligand within the cell, or surrounding HL-60 cells. For example, ICAM-3 is expressed on neutrophils, serving as a ligand for &#x3b1;D&#x3b2;2. ICAM-3 binding to neutrophils induces apoptosis (<xref ref-type="bibr" rid="B36">36</xref>), so the deficiency of &#x3b1;D&#x3b2;2 may lessen this interaction, leading to less apoptosis.</p>
<p>From sepsis standpoint, lung injury is one of the most serious organ injuries that patients succumbed to. The mortality of patients with lung injury in sepsis is quite high. Thus, our finding will offer a very interesting target for sepsis therapeutic. So far there is no &#x3b1;D&#x3b2;2 antagonist reported. We primarily focused on the role of &#x3b1;D&#x3b2;2 in sepsis in this study. It is also interesting to examine the role of this molecule in other disease states such as cancers. Among &#x3b2;2 integrin members, &#x3b1;M&#x3b2;2 has been most extensively studied in the context of cancer. Its inhibition enhanced tumor response to radiation (<xref ref-type="bibr" rid="B37">37</xref>). Its deficiency suppressed intestinal tumor growth (<xref ref-type="bibr" rid="B38">38</xref>). However, its agonist LA1 was reported to attenuate tumor growth (<xref ref-type="bibr" rid="B39">39</xref>). Thus, the role of &#x3b1;M&#x3b2;2 in cancer may not be straightforward. So far there is a limited data available on the role of &#x3b1;D&#x3b2;2 in cancer, which needs future study.</p>
<p>In conclusion, we found a novel role of &#x3b1;D&#x3b2;2 in neutrophils and sepsis. Delineating the underlying mechanism of &#x3b1;D&#x3b2;2-mediated modulation of neutrophil functions will help us to understand how &#x3b1;D&#x3b2;2 contributes to sepsis pathophysiology for considering as a future therapeutic target.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The data presented in the study are deposited in the Gene Expression Omnibus (GEO) repository accession number GSE215749. </p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was reviewed and approved by Boston Children&#x2019;s Hospital IACUC.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>SK - Designed experiment, performed experiment and wrote manuscript. LH - Designed experiment and performed experiment. TO - Designed experiment and performed experiment MS-F - Designed experiment and performed experiment. HL - Designed experiment KY - Designed experiment, performed experiment and wrote manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This study was in part supported by R21HD099194 (KY, SK).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishimoto</surname> <given-names>TK</given-names>
</name>
<name>
<surname>Springer</surname> <given-names>TA</given-names>
</name>
</person-group>. <article-title>Human leukocyte adhesion deficiency: Molecular basis for a defective immune response to infections of the skin</article-title>. <source>Curr Probl Dermatol</source> (<year>1989</year>) <volume>18</volume>:<page-range>106&#x2013;15</page-range>. doi: <pub-id pub-id-type="doi">10.1159/000416845</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname> <given-names>R</given-names>
</name>
<name>
<surname>Patzak</surname> <given-names>I</given-names>
</name>
<name>
<surname>Svensson</surname> <given-names>L</given-names>
</name>
<name>
<surname>De Filippo</surname> <given-names>K</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>K</given-names>
</name>
<name>
<surname>McDowall</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Integrins in immunity</article-title>. <source>J Cell Sci</source> (<year>2009</year>) <volume>122</volume>:<page-range>215&#x2013;25</page-range>. doi: <pub-id pub-id-type="doi">10.1242/jcs.019117</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunne</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Ballantyne</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Beaudet</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Ley</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Control of leukocyte rolling velocity in TNF-alpha-induced inflammation by LFA-1 and mac-1</article-title>. <source>Blood</source> (<year>2002</year>) <volume>99</volume>:<page-range>336&#x2013;41</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood.V99.1.336</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname> <given-names>ES</given-names>
</name>
<name>
<surname>McIntyre</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Prescott</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Zimmerman</surname> <given-names>GA</given-names>
</name>
</person-group>. <article-title>The leukocyte integrins</article-title>. <source>J Biol Chem</source> (<year>2000</year>) <volume>275</volume>:<page-range>23409&#x2013;12</page-range>. doi: <pub-id pub-id-type="doi">10.1074/jbc.R000004200</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Han</surname> <given-names>X</given-names>
</name>
<name>
<surname>Soriano</surname> <given-names>SG</given-names>
</name>
<name>
<surname>Yuki</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>The role of macrophage 1 antigen in polymicrobial sepsis</article-title>. <source>Shock</source> (<year>2014</year>) <volume>42</volume>:<page-range>532&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1097/SHK.0000000000000250</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Han</surname> <given-names>X</given-names>
</name>
<name>
<surname>Soriano</surname> <given-names>SG</given-names>
</name>
<name>
<surname>Yuki</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Leukocyte function-associated antigen-1 deficiency impairs responses to polymicrobial sepsis</article-title>. <source>World J Clin cases</source> (<year>2015</year>) <volume>3</volume>:<fpage>793</fpage>&#x2013;<lpage>806</lpage>. doi: <pub-id pub-id-type="doi">10.12998/wjcc.v3.i9.793</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koutsogiannaki</surname> <given-names>S</given-names>
</name>
<name>
<surname>Schaefers</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Okuno</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ohba</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yokomizo</surname> <given-names>T</given-names>
</name>
<name>
<surname>Priebe</surname> <given-names>GP</given-names>
</name>
<etal/>
</person-group>. <article-title>From the cover: Prolonged exposure to volatile anesthetic isoflurane worsens the outcome of polymicrobial abdominal sepsis</article-title>. <source>Toxicol Sci</source> (<year>2017</year>) <volume>156</volume>:<page-range>402&#x2013;11</page-range>. doi: <pub-id pub-id-type="doi">10.1093/toxsci/kfw261</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Voit</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Sankaran</surname> <given-names>VG</given-names>
</name>
<name>
<surname>Springer</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Yuki</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>CD11c regulates hematopoietic stem and progenitor cells under stress</article-title>. <source>Blood Adv</source> (<year>2020</year>) <volume>4</volume>:<page-range>6086&#x2013;97</page-range>. doi: <pub-id pub-id-type="doi">10.1182/bloodadvances.2020002504</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>RF</given-names>
</name>
<name>
<surname>Riedemann</surname> <given-names>NC</given-names>
</name>
<name>
<surname>Laudes</surname> <given-names>IJ</given-names>
</name>
<name>
<surname>Sarma</surname> <given-names>VJ</given-names>
</name>
<name>
<surname>Kunkel</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Dilley</surname> <given-names>KA</given-names>
</name>
<etal/>
</person-group>. <article-title>Altered neutrophil trafficking during sepsis</article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>169</volume>:<page-range>307&#x2013;14</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.169.1.307</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seekamp</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mulligan</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Till</surname> <given-names>GO</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Miyasaka</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tamatani</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of beta 2 integrins and ICAM-1 in lung injury following ischemia-reperfusion of rat hind limbs</article-title>. <source>Am J Pathol</source> (<year>1993</year>) <volume>143</volume>:<page-range>464&#x2013;72</page-range>.</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Peters</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Alhazzani</surname> <given-names>W</given-names>
</name>
<name>
<surname>Agus</surname> <given-names>MSD</given-names>
</name>
<name>
<surname>Flori</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Inwald</surname> <given-names>DP</given-names>
</name>
<etal/>
</person-group>. <article-title>Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children</article-title>. <source>Pediatr Crit Care Med</source> (<year>2020</year>) <volume>21</volume>:<fpage>e52</fpage>&#x2013;<lpage>106</lpage>. doi: <pub-id pub-id-type="doi">10.1097/PCC.0000000000002198</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname> <given-names>ZM</given-names>
</name>
<name>
<surname>Babensee</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Simon</surname> <given-names>SI</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Perrard</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Bullard</surname> <given-names>DC</given-names>
</name>
<etal/>
</person-group>. <article-title>Relative contribution of LFA-1 and mac-1 to neutrophil adhesion and migration</article-title>. <source>J Immunol</source> (<year>1999</year>) <volume>163</volume>:<page-range>5029&#x2013;38</page-range>.</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coxon</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rieu</surname> <given-names>P</given-names>
</name>
<name>
<surname>Barkalow</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Askari</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sharpe</surname> <given-names>AH</given-names>
</name>
<name>
<surname>von Andrian</surname> <given-names>UH</given-names>
</name>
<etal/>
</person-group>. <article-title>A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation</article-title>. <source>Immunity</source> (<year>1996</year>) <volume>5</volume>:<page-range>653&#x2013;66</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S1074-7613(00)80278-2</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Rodgers</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Perrard</surname> <given-names>XY</given-names>
</name>
<name>
<surname>Perrard</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Prince</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Abe</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic changes</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>173</volume>:<fpage>297</fpage>&#x2013;<lpage>306</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.173.1.297</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koutsogiannaki</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bernier</surname> <given-names>R</given-names>
</name>
<name>
<surname>Tazawa</surname> <given-names>K</given-names>
</name>
<name>
<surname>Yuki</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Volatile anesthetic attenuates phagocyte function and worsens bacterial loads in wounds</article-title>. <source>J Surg Res</source> (<year>2019</year>) <volume>233</volume>:<page-range>323&#x2013;30</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jss.2018.07.075</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osaka</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ito</surname> <given-names>S</given-names>
</name>
<name>
<surname>Honda</surname> <given-names>M</given-names>
</name>
<name>
<surname>Inomata</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Egashira</surname> <given-names>K</given-names>
</name>
<name>
<surname>Yoshida</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Critical role of the C5a-activated neutrophils in high-fat diet-induced vascular inflammation</article-title>. <source>Sci Rep</source> (<year>2016</year>) <volume>6</volume>:<fpage>21391</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep21391</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erickson</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>GS</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Matthay</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Eisner</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Network</surname> <given-names>NNA</given-names>
</name>
</person-group>. <article-title>Recent trends in acute lung injury mortality: 1996-2005</article-title>. <source>Crit Care Med</source> (<year>2009</year>) <volume>37</volume>:<page-range>1574&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1097/CCM.0b013e31819fefdf</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okuno</surname> <given-names>T</given-names>
</name>
<name>
<surname>Koutsogiannaki</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Ohto</surname> <given-names>U</given-names>
</name>
<name>
<surname>Eckenhoff</surname> <given-names>RG</given-names>
</name>
<etal/>
</person-group>. <article-title>Volatile anesthetics isoflurane and sevoflurane directly target and attenuate toll-like receptor 4 system</article-title>. <source>FASEB J</source> (<year>2019</year>) <volume>33</volume>:<page-range>14528&#x2013;41</page-range>. doi: <pub-id pub-id-type="doi">10.1096/fj.201901570R</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bak</surname> <given-names>RO</given-names>
</name>
<name>
<surname>Dever</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Porteus</surname> <given-names>MH</given-names>
</name>
</person-group>. <article-title>CRISPR/Cas9 genome editing in human hematopoietic stem cells</article-title>. <source>Nat Protoc</source> (<year>2018</year>) <volume>13</volume>:<page-range>358&#x2013;76</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nprot.2017.143</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bao</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Nandakumar</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Bick</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Karjalainen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tabaka</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells</article-title>. <source>Nature</source> (<year>2020</year>) <volume>586</volume>:<page-range>769&#x2013;75</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41586-020-2786-7</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaidyanathan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Salahudeen</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Sellers</surname> <given-names>ZM</given-names>
</name>
<name>
<surname>Bravo</surname> <given-names>DT</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Batish</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>High-efficiency, selection-free gene repair in airway stem cells from cystic fibrosis patients rescues CFTR function in differentiated epithelia</article-title>. <source>Cell Stem Cell</source> (<year>2020</year>) <volume>26</volume>:<fpage>161</fpage>&#x2013;<lpage>71.e164</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.stem.2019.11.002</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buras</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Holzmann</surname> <given-names>B</given-names>
</name>
<name>
<surname>Sitkovsky</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Animal models of sepsis: setting the stage</article-title>. <source>Nat Rev Drug Discov</source> (<year>2005</year>) <volume>4</volume>:<page-range>854&#x2013;65</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nrd1854</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rittirsch</surname> <given-names>D</given-names>
</name>
<name>
<surname>Huber-Lang</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Flierl</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Ward</surname> <given-names>PA</given-names>
</name>
</person-group>. <article-title>Immunodesign of experimental sepsis by cecal ligation and puncture</article-title>. <source>Nat Protoc</source> (<year>2009</year>) <volume>4</volume>:<page-range>31&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nprot.2008.214</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname> <given-names>BT</given-names>
</name>
<name>
<surname>Chambers</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>KD</given-names>
</name>
</person-group>. <article-title>Acute respiratory distress syndrome</article-title>. <source>N Engl J Med</source> (<year>2017</year>) <volume>377</volume>:<page-range>1904&#x2013;5</page-range>. doi: <pub-id pub-id-type="doi">10.1056/NEJMra1608077</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hotchkiss</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>KC</given-names>
</name>
<name>
<surname>Swanson</surname> <given-names>PE</given-names>
</name>
<name>
<surname>Tinsley</surname> <given-names>KW</given-names>
</name>
<name>
<surname>Hui</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Klender</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte</article-title>. <source>Nat Immunol</source> (<year>2000</year>) <volume>1</volume>:<fpage>496</fpage>&#x2013;<lpage>501</lpage>. doi: <pub-id pub-id-type="doi">10.1038/82741</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hotchkiss</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Nicholson</surname> <given-names>DW</given-names>
</name>
</person-group>. <article-title>Apoptosis and caspases regulate death and inflammation in sepsis</article-title>. <source>Nat Rev Immunol</source> (<year>2006</year>) <volume>6</volume>:<page-range>813&#x2013;22</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri1943</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koutsogiannaki</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Babazada</surname> <given-names>H</given-names>
</name>
<name>
<surname>Okuno</surname> <given-names>T</given-names>
</name>
<name>
<surname>Blazon-Brown</surname> <given-names>N</given-names>
</name>
<name>
<surname>Soriano</surname> <given-names>SG</given-names>
</name>
<etal/>
</person-group>. <article-title>The volatile anesthetic sevoflurane reduces neutrophil apoptosis <italic>via</italic> fas death domain-fas-associated death domain interaction</article-title>. <source>FASEB J</source> (<year>2019</year>) <volume>33</volume>:<page-range>12668&#x2013;79</page-range>. doi: <pub-id pub-id-type="doi">10.1096/fj.201901360R</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aziz</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>K</given-names>
</name>
<name>
<surname>Das</surname> <given-names>M</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Ardell</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Febbraio</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The upregulation of integrin alphaDbeta2 (CD11d/CD18) on inflammatory macrophages promotes macrophage retention in vascular lesions and development of atherosclerosis</article-title>. <source>J Immunol</source> (<year>2017</year>) <volume>198</volume>:<page-range>4855&#x2013;67</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1602175</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyazaki</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Vieira-de-Abreu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Harris</surname> <given-names>ES</given-names>
</name>
<name>
<surname>Shah</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Weyrich</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Castro-Faria-Neto</surname> <given-names>HC</given-names>
</name>
<etal/>
</person-group>. <article-title>Integrin alphaDbeta2 (CD11d/CD18) is expressed by human circulating and tissue myeloid leukocytes and mediates inflammatory signaling</article-title>. <source>PloS One</source> (<year>2014</year>) <volume>9</volume>:<elocation-id>e112770</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0112770</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van der Vieren</surname> <given-names>M</given-names>
</name>
<name>
<surname>Le Trong</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>PF</given-names>
</name>
<name>
<surname>St John</surname> <given-names>T</given-names>
</name>
<name>
<surname>Staunton</surname> <given-names>DE</given-names>
</name>
<etal/>
</person-group>. <article-title>A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3</article-title>. <source>Immunity</source> (<year>1995</year>) <volume>3</volume>:<page-range>683&#x2013;90</page-range>. doi: <pub-id pub-id-type="doi">10.1016/1074-7613(95)90058-6</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yakubenko</surname> <given-names>VP</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ardell</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>KE</given-names>
</name>
<name>
<surname>West</surname> <given-names>XZ</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Oxidative modifications of extracellular matrix promote the second wave of inflammation <italic>via</italic> beta2 integrins</article-title>. <source>Blood</source> (<year>2018</year>) <volume>132</volume>:<fpage>78</fpage>&#x2013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1182/blood-2017-10-810176</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geremia</surname> <given-names>NM</given-names>
</name>
<name>
<surname>Hryciw</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>F</given-names>
</name>
<name>
<surname>Streijger</surname> <given-names>F</given-names>
</name>
<name>
<surname>Okon</surname> <given-names>E</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JHT</given-names>
</name>
<etal/>
</person-group>. <article-title>The effectiveness of the anti-CD11d treatment is reduced in rat models of spinal cord injury that produce significant levels of intraspinal hemorrhage</article-title>. <source>Exp Neurol</source> (<year>2017</year>) <volume>295</volume>:<page-range>125&#x2013;34</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.expneurol.2017.06.002</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saville</surname> <given-names>LR</given-names>
</name>
<name>
<surname>Pospisil</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Mawhinney</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>F</given-names>
</name>
<name>
<surname>Simedrea</surname> <given-names>FC</given-names>
</name>
<name>
<surname>Peters</surname> <given-names>AA</given-names>
</name>
<etal/>
</person-group>. <article-title>A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment</article-title>. <source>J Neuroimmunol</source> (<year>2004</year>) <volume>156</volume>:<fpage>42</fpage>&#x2013;<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jneuroim.2004.07.002</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Azevedo-Quintanilha</surname> <given-names>IG</given-names>
</name>
<name>
<surname>Vieira-de-Abreu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Nascimento</surname> <given-names>DO</given-names>
</name>
<name>
<surname>Siqueira</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Campbell</surname> <given-names>RA</given-names>
</name>
<etal/>
</person-group>. <article-title>Integrin alphaDbeta2 (CD11d/CD18) mediates experimental malaria-associated acute respiratory distress syndrome (MA-ARDS)</article-title>. <source>Malar J</source> (<year>2016</year>) <volume>15</volume>:<fpage>393</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12936-016-1447-7</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayadas</surname> <given-names>TN</given-names>
</name>
<name>
<surname>Cullere</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Neutrophil beta2 integrins: moderators of life or death decisions</article-title>. <source>Trends Immunol</source> (<year>2005</year>) <volume>26</volume>:<page-range>388&#x2013;95</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.it.2005.05.002</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kessel</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Sedgwick</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Busse</surname> <given-names>WW</given-names>
</name>
</person-group>. <article-title>Ligation of intercellular adhesion molecule 3 induces apoptosis of human blood eosinophils and neutrophils</article-title>. <source>J Allergy Clin Immunol</source> (<year>2006</year>) <volume>118</volume>:<page-range>831&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2006.05.026</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahn</surname> <given-names>GO</given-names>
</name>
<name>
<surname>Tseng</surname> <given-names>D</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Dorie</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Czechowicz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>JM</given-names>
</name>
</person-group>. <article-title>Inhibition of mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2010</year>) <volume>107</volume>:<page-range>8363&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0911378107</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>QQ</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>XW</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>YL</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>ZJ</given-names>
</name>
<name>
<surname>Gui</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>DL</given-names>
</name>
<etal/>
</person-group>. <article-title>CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment</article-title>. <source>Sci Rep</source> (<year>2015</year>) <volume>5</volume>:<fpage>15948</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep15948</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmid</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>SQ</given-names>
</name>
<name>
<surname>Kaneda</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Pathria</surname> <given-names>P</given-names>
</name>
<name>
<surname>Shepard</surname> <given-names>R</given-names>
</name>
<name>
<surname>Louis</surname> <given-names>TL</given-names>
</name>
<etal/>
</person-group>. <article-title>Integrin CD11b activation drives anti-tumor innate immunity</article-title>. <source>Nat Commun</source> (<year>2018</year>) <volume>9</volume>:<fpage>5379</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-018-07387-4</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>